Patent AT-E401083-T1: [Translated] METHOD USING ESTROGEN/PROGESTIN/ANTIPROGESTIN AND DEVICE FOR ORAL CONTRACEPTION AND REGULATION OF MENSTRATION
MENSES REGULATION AND, WHEN DESIRED, CONTRACEPTION IS ACHIEVED AT LOW DOSES OF ESTROGEN AND PROGESTIN, WHICH OTHERWISE WOULD CREATE EPISODES OF BREAKTHROUGH BLEEDING AND/OR WITHDRAWAL AMENORRHEA, BY PERIODICALLY INDUCING MENSES WITH AN ANTIPROGESTIN.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[
"009:25"
]
|
| contactPoint |
{
"fn": "NIH/NCBI Data Team",
"@type": "vcard:Contact",
"hasEmail": "mailto:info@ncbi.nlm.nih.gov"
}
|
| description | MENSES REGULATION AND, WHEN DESIRED, CONTRACEPTION IS ACHIEVED AT LOW DOSES OF ESTROGEN AND PROGESTIN, WHICH OTHERWISE WOULD CREATE EPISODES OF BREAKTHROUGH BLEEDING AND/OR WITHDRAWAL AMENORRHEA, BY PERIODICALLY INDUCING MENSES WITH AN ANTIPROGESTIN. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Official Data Source",
"mediaType": "text/html",
"description": "Access the complete Patent AT-E401083-T1: [Translated] METHOD USING ESTROGEN/PROGESTIN/ANTIPROGESTIN AND DEVICE FOR ORAL CONTRACEPTION AND REGULATION OF MENSTRATION on the official website.",
"downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E401083-T1"
}
]
|
| identifier | https://healthdata.gov/api/views/3yeu-4xg2 |
| issued | 2025-09-05 |
| keyword |
[
"chemistry",
"innovation",
"patent",
"pubchem",
"research"
]
|
| landingPage | https://healthdata.gov/d/3yeu-4xg2 |
| modified | 2025-09-06 |
| programCode |
[
"009:066"
]
|
| publisher |
{
"name": "National Center for Biotechnology Information (NCBI)",
"@type": "org:Organization"
}
|
| theme |
[
"NIH"
]
|
| title | Patent AT-E401083-T1: [Translated] METHOD USING ESTROGEN/PROGESTIN/ANTIPROGESTIN AND DEVICE FOR ORAL CONTRACEPTION AND REGULATION OF MENSTRATION |
